Paget's disease of the vulva was described 100 years ago. 1 It is rare and there still is a limited understanding about its association with cancer. Most cases of Paget's disease of the vulva are adenocarcinoma in situ disease; however, in some cases there is an associated invasive adenocarcinoma present. Previous studies 2, 3 have suggested that the frequency of occurrence of an associated underlying carcinoma is of the order of 10-30%. Some theories suggest that intraepidermal adenocarcinoma cells have metastasised to the overlying surface from the underlying carcinoma, whereas others have suggested that Paget cells migrate downwards to develop invasive disease. 4 In contrast to Paget's disease of the vulva, the general consensus for Paget's disease of the breast, which was originally described by Sir James Paget in 1874, 5 is that almost all cases are associated with a ductal carcinoma in situ (DCIS) or an invasive ductal carcinoma. 6 Cells within the epidermis are held together by a number of adhesion complexes and their associated proteins. The growth of many cancer cells has been linked to the loss of negative regulation of cell proliferation conferred by cell-cell adhesion. The reduced expression or lack of cell adhesion molecules has therefore been implicated in the invasion and metastatic process. 7 Loss or decreased cell adhesiveness has been demonstrated in cancers and thought to represent a greater risk of tumour dissemination. 8 E-cadherin is a member of a multifunctional family of calcium-dependent, transmembrane glycoproteins, which promote and maintain cell adhesion. 9 In vitro experiments have demonstrated E-cadherin to have invasion-suppressing properties. 10, 11 Downregulation of E-cadherin expression has been documented in breast 12 and oesophageal carcinomas, 7 squamous cell carcinomas of the skin 13 and bladder carcinomas. 14 Plakoglobin and b-catenin are closely related proteins that have a key role in cell adhesion (adherens junctions), 15 activation of transcriptional factors, for example, T-cell factor (Tcf) 16 and in the Wnt wingless-signalling pathways, 17 an important pathway in the development of the cell and cancer.
The objective of this study was to determine whether expression of E-cadherin, plakoglobin and b-catenin correlated with disease progression in Paget's disease of the vulva and Paget's disease of the breast, in order to investigate the role of the proteins as potential diagnostic markers. This study complements our other work investigating the role of the cell cycle and angiogenesis in Paget's disease of the vulva and Paget's disease of the breast.
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Materials and methods
Tissue Specimens
Ethical approval has been granted by the Royal Free Hospital NHS Trust.
Sixty-three cases of Paget's disease of the vulva, including eight associated with invasive disease, and 23 cases of Paget's disease of the breast, which included 10 cases with DCIS alone, four cases with both DCIS and invasive carcinoma, five with an underlying invasive carcinoma, and four with Paget's disease of the breast alone, were analysed for expression of E-cadherin, plakoglobin and b-catenin. These cases were retrieved from the Histopathology Department at the Royal Free Hampstead NHS Trust, and from collaborators as listed in the acknowledgement section. The cases were diagnosed and treated between 1984 and 2000.
The archival cases had all been formalin-fixed and paraffin wax-embedded. Drs Diaz-Cano (SDC) and Julie C Crow (JCC; collaborating Histopathologists) reviewed all haematoxylin and eosin-stained slides of the cases to confirm diagnosis of Paget's disease.
Immunohistochemistry
The streptavidin-biotin-peroxidase detection system was employed for immunohistochemistry.
Paraffin wax-embedded sections of Paget's tissue, 5-mm thick, were cut and mounted on aminopropyltriethoxysilane-coated glass slides. The sections were deparaffinised in xylene (2 Â 5 min) and rehydrated in graded solutions of ethanol (100, 90 and 70%, 3 min each). To block endogenous peroxidase, sections were immersed in 3% hydrogen peroxide in methanol for 10 min. The sections were then left in running water (2 min). Conditions for antigen retrieval, incubation times and the primary antibodies used are described in Table 1 . Sections were incubated with the secondary antibody, biotinylated rabbit anti-mouse IgG (1:50 dilution in phosphate buffered-saline, PBS; Dako) for 30 min and washed in PBS (3 Â 5 min). Addition of streptavidin-biotinhorseradish peroxidase complex (Dako) to the sections (1:500 dilution in Tris-buffered saline) for 30 min was followed by a further wash in PBS (3 min). Antibody binding was visualised with a solution containing the chromogen 3,3 0 -diaminobenzidine (Sigma-Aldrich, Poole, UK). The sections were counterstained with Mayer's haematoxylin (Merck, Lutterworth, UK). Finally, slides were rehydrated in graded ethanol rinses, cleared in xylene and mounted in DPX.
Normal vulval skin was used as positive control for cases of Paget's disease of the vulva, and normal breast skin was for cases of Paget's disease of the breast. Apocrine and eccrine glands were used as internal controls. For negative controls, the primary antibodies were replaced by PBS. Sections were stained on two separate occasions and scored separately by two individuals (SDC, PEE) to ensure reproducibility. There was o5% variation between sections and observers. The location of the pattern of staining of the protein was recorded as one of the following: membranous, diffuse cytoplasmic, paranuclear and nuclear. To score, initially four quarters as a percentage of Paget cells expressing each protein were used. However, since the numbers were small in each group, 50% positivity was used as threshold. The intensity of staining was also recorded as either nil, mild or strong.
In Situ Hybridisation
Paraffin-wax-embedded sections (5-mm thick) were cut on Superfrost slides (Merk). Sections were deparaffinised, microwaved in pre-warmed 10% citrate buffer (10 min) and pre-hybridised at 421C for 4 h. Following this, sections were hybridised with 40 ng/ml of digoxigenin-labelled cRNA probe in pre-hybridisation buffer containing 20% dextran sulphate for overnight at 421C, using a Hybaid Omnislide machine. Following stringency washes to 0.1 Â SCC/50% formamide, sections were stained with anti-digoxigenin-alkaline phosphatase Fab fragments. After washing, sections were developed with nitroblue tetrazolium chloride/bromo-chloroidoly-phosophate (Sigma) chromogen solutions. Stained sections were scored for intensity of the mRNA signal at the intracellular junctions. Nuclear and cytoplasmic staining were recorded separately. Sections were stained on two separate occasions and the results analysed by two independent observers (PEE and Lucy Ghali (LG)). There was o5% variation between sections and observers. The surrounding apocrine glands and epidermal cells were used as positive controls. The sense (mRNA) probe was used as the negative control. Primer sequences for E-cadherin, plakoglobin and b-catenin are described in Table 1 .
Statistical Analysis
Statistical analysis was performed by w 2 and Fisher's exact tests, as appropriate. A P-value of o0.05 was considered significant.
Results
Evaluation of E-cadherin, Plakoglobin and b-Catenin in Paget's Disease of the Vulva Without Invasive Disease
Forty-one of the 54 (76%) cases of Paget's disease of the vulva without invasive disease had 450% of Paget cells expressing E-cadherin (Figure 1 ). The staining pattern was membranous and the intensity of staining was mostly strong.
Six cases were suitable for scoring E-cadherin mRNA. Decreased mRNA signal in the Paget cells (Figure 2 ) was noted in all cases, as compared with the surrounding apocrine glands and epidermal cells.
Fourteen of 55 (25%) cases had 450% of Paget cells expressing plakoglobin compared with 74% with a score of o50% (Figure 3) . In most cases the staining pattern was membranous and the staining intensity mild. Ten Paget's disease of the vulva cases were analysed for plakoglobin mRNA, but only eight were suitable for scoring. All cases had decreased mRNA signal in the Paget cells, compared with in the apocrine and epidermal cells.
Only 5 of 55 (9%) cases had 450% of Paget cells expressing the b-catenin protein, compared with 50 of 55 (91%) of cases with o50% ( Figure 4) . Again, staining was membranous and intensity was mild. Fifteen cases were analysed for b-catenin mRNA, but only nine were suitable for scoring. Eight cases revealed decreased mRNA signal in the Paget cells, compared with the surrounding apocrine glands and epidermal cells. One of eight (12%) cases had 450% of Paget cells expressing the plakoglobin and b-catenin protein, respectively. The results were not significant when comparing with Paget's disease of the vulva cases without invasive disease. The staining pattern was found to be membranous, cytoplasmic and nuclear, and staining intensity was mild. One case of invasive Paget's disease of the vulva was suitable for scoring E-cadherin and plakoglobin mRNA. Decreased mRNA signal in the Paget cells was noted in both cases as compared with the surrounding apocrine glands and epidermal cells. The results are presented in Table 2 . (Figure 6 ). There was no significant difference between the subsets of Paget's disease of the breast expressing E-cadherin, plakoglobin and b-catenin proteins. Table 2 shows the subsets' combined expression of E-cadherin, plakoglobin and b-catenin proteins. Nine of the 14 Paget's disease of breast cases, which included 4 with associated DCIS, 4 with invasive carcinoma and one case of Paget's disease of the breast only, analysed were suitable for E-cadherin mRNA scoring. In all cases, the mRNA signal was found to be reduced in the Paget cells as compared with the surrounding apocrine glands and epidermal cells. 
E-cadherin expression in Paget's disease of the vulva and breast PE Ellis et al
Eight of 11 cases of Paget's disease of the breast, which included 5 with associated DCIS, 4 with invasive carcinoma and 2 with Paget's disease of the breast only, were suitable for scoring mRNA plakoglobin. The mRNA signal was noted to be decreased or absent in the Paget cells, as compared with the surrounding apocrine glands and epidermal cells.
Thirteen cases of Paget's disease of the breast were analysed for b-catenin mRNA, which included 6 with associated DCIS, 4 with invasive carcinoma and 2 with Paget's disease of breast only. In the 12 cases that were suitable for scoring, mRNA signal was noted to be decreased in 10 cases as compared with the surrounding apocrine glands and epidermal cells (Figure 7) . The signal was found to be similar in intensity in both the antisense and sense slides in two cases.
Discussion
E-cadherin Expression in Paget's Disease of the Vulva
This is the largest study of E-cadherin, plakoglobin and b-catenin expression in Paget's disease of the vulva and Paget's disease of the breast of which we are aware. Since loss of expression of E-cadherin has been suggested as one of the mechanisms contributing to development of invasion and metastasis of cancer cells, its expression has been investigated in several cancers with a view to correlating lack of expression with invasive disease. Only two smaller studies have examined this role in Paget's disease of the vulva. The Shirahama et al study 20 found that E-cadherin was not expressed in their three cases of Paget's disease of the vulva, and Tada and coworkers 21 showed decreased expression of E-cadherin in their invasive Paget's disease of the vulva (four cases) compared with the in situ cases (four cases).
In the current study we found similar results. E-cadherin expression was significantly reduced (P ¼ 0.039) in the intraepidermal compartment of the Paget's disease of the vulva cases with invasive disease when compared with the intraepidermal compartment of Paget's disease of the vulva cases without invasive disease. Loss of E-cadherin expression is likely to lead to reduced cell adhesiveness and therefore detachment of Paget cells from the intraepidermal lesion, the result being invasive disease. There appeared to be no significant difference in the cellular localisation of the proteins between non-invasive and invasive Paget's disease of the vulva.
There was a decrease in mRNA signal intensity when compared with the surrounding apocrine glands and epidermal cells, in both non-invasive Paget's disease of the vulva, and in those cases associated with invasive disease, suggesting decreased transcriptional regulation of the protein rather than factors affecting its stability and degradation.
Plakoglobin Expression in Paget's Disease of the Vulva
The reduced expression of cell adhesion molecules has been implicated in promoting invasion and metastasis. 22, 23 There is a paucity of information regarding expression of plakoglobin, E-cadherin and b-catenin in Paget's disease of the vulva and, as such, the role of these molecules has not been clearly established in Paget's disease of the vulva. 20, 21, 24 To our knowledge, only one study has examined the expression of plakoglobin in Paget's disease of the vulva. Tada et al 24 examined the expression of desmoglein I and plakoglobin in skin carcinomas, which included 11 cases of extramammary Paget's disease; only one case was from a female of which the location was documented as the pudendum. This case was negative for plakoglobin. In the current study, fewer Paget cells expressed plakoglobin in the intraepidermal compartment of the Paget cases with invasive disease when compared with the intraepidermal compartment of Paget's disease cases without invasive disease, although this did not reach statistical significance. Plakoglobin mRNA signal was also decreased compared with the surrounding apocrine glands. These findings may suggest a possible dysfunction in the regulation of plakoglobin in Paget's disease of the vulva with invasive disease, as compared with those cases without invasion. Nuclear and diffuse cytoplasmic staining of the plakoglobin protein was noted in 13 of the cases, with only one case being associated with invasive disease.
b-Catenin Expression in Paget's Disease of the Vulva
The transcriptional activity of b-catenin and its degradation are regulated by the Wnt pathway. In normal epithelial cells, b-catenin is localised at the cell membrane. The unbound b-catenin is degraded by the ubiquitin-proteasome system, which involves the GSK-3b. Stabilisation of cytoplasmic b-catenin by aberrant activation of Wnt signalling leads to its accumulation, complex with lymphoid enhancer factor/Tcf (LEF/Tcf) transcription factors and transactivation of LEF/Tcf target genes. Activation of these genes can lead to cell proliferation or inhibition of apoptosis. Nuclear accumulation of b-catenin can be the result of gene mutations. 25 In colon cancers, disruption of the Wnt-signalling pathway by mutations of either the adenomatous polyposis coli or the b-catenin gene plays a crucial part in the early stage of tumorigenesis. 26 In the current study, diffuse cytoplasmic and paranuclear staining of the b-catenin protein was found in 11 and four cases of Paget's disease of the vulva, respectively. Three of these cases were of Paget's disease of the vulva with invasion. These results may suggest involvement of aberrant activation of the Wnt-signalling pathway in some cases of Paget's disease of the vulva.
E-cadherin Expression in Paget's Disease of the Breast
The role of E-cadherin in breast cancers is debatable. Reduced expression of E-cadherin has been reported to be associated with poor outcome, 27 whereas other investigators have demonstrated no independent prognostic value for E-cadherin in breast carcinomas. 28, 29 To our knowledge, only one study 21 has examined the expression of E-cadherin in Paget's disease of the breast, and both cases were negative for the protein. In contrast, in our larger study, 65% of the Paget's disease of the breast cases in our study had 450% of Paget cells expressing E-cadherin. It is therefore unlikely that reduced E-cadherinmediated cell-cell adhesion is an important factor in the pathogenesis of Paget's disease of the breast.
Plakoglobin Expression in Paget's Disease of the Breast
Plakoglobin has not been examined in Paget's disease of the breast, although it has been examined in primary breast carcinomas. [30] [31] [32] [33] Loss of heterozygosity and reduced expression of plakoglobin associated with disease progression have been demonstrated in breast cancer. In the current study, only 17% of the cases of Paget disease of the breast had 450% of Paget cells expressing plakoglobin. This implicates a possible role for plakoglobin in the formation of Paget's disease of the breast. There was good correlation between plakoglobin mRNA and protein expression.
b-Catenin Expression in Paget's Disease of the Breast
Few studies have sought to examine the role of b-catenin in breast carcinomas, 30, 31 and none have examined b-catenin in Paget's disease of the breast. Forty-eight percent of our cases of Paget's disease of the breast had nuclear and paranuclear staining of b-catenin protein. The extramembranous accumulation could be due to mutation in the b-catenin gene or its lack of degradation by the APC/GSK3b/ proteasome system. Except in one case, there was good correlation between mRNA signal and protein expression.
The adhesive function of cadherins is dependent on their interaction with catenins. Some reports have revealed reduced expression of both cadherins and catenins in certain tumours, for example, oral squamous cell carcinoma. 34 In the current study, there appeared to be no correlation between reduced expression of E-cadherin and b-catenin.
In summary, reduced expression of E-cadherin may a have a role in the pathogenesis of Paget's disease of the vulva with invasive disease, unlike in Paget's disease of the breast, where in the majority of cases, normal expression of the protein was demonstrated. Abnormal plakoglobin expression may be involved in some cases of Paget's disease of the vulva and Paget's disease of the breast. These results suggest that there may be different mechanisms underlying the aetiology of these two diseases, and loss of cell-cell adhesion may be an important factor in their development.
